Biochemical and structural analysis of 14 mutant adsl enzyme complexes and correlation to phenotypic heterogeneity of adenylosuccinate lyase deficiency
Language English Country United States Media print
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
20127976
DOI
10.1002/humu.21212
Knihovny.cz E-resources
- MeSH
- Adenylosuccinate Lyase chemistry deficiency genetics MeSH
- Electrophoresis, Polyacrylamide Gel MeSH
- Phenotype MeSH
- Genetic Heterogeneity * MeSH
- Humans MeSH
- Multienzyme Complexes chemistry deficiency genetics MeSH
- Mutation genetics MeSH
- Mutant Proteins chemistry genetics MeSH
- Infant, Newborn MeSH
- Protein Structure, Secondary MeSH
- Enzyme Stability MeSH
- Structure-Activity Relationship MeSH
- Check Tag
- Humans MeSH
- Infant, Newborn MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Adenylosuccinate Lyase MeSH
- Multienzyme Complexes MeSH
- Mutant Proteins MeSH
Adenylosuccinate lyase (ADSL) deficiency is neurometabolic disease characterized by accumulation of dephosphorylated enzyme substrates SAICA-riboside (SAICAr) and succinyladenosine (S-Ado) in body fluids of affected individuals. The phenotypic severity differs considerably among patients: neonatal fatal, severe childhood, and moderate phenotypic forms correlating with different values for the ratio between S-Ado and SAICAr concentrations in cerebrospinal fluid have been distinguished. To reveal the biochemical and structural basis for this phenotypic heterogeneity, we expressed and characterized 19 ADSL mutant proteins identified in 16 patients representing clinically distinct subgroups. Respecting compound heterozygosity and considering the homotetrameric structure of ADSL, we used intersubunit complementation and prepared and characterized genotype-specific heteromeric mutant ADSL complexes. We correlated clinical phenotypes with biochemical properties of the mutant proteins and predicted structural impacts of the mutations. We found that phenotypic severity in ADSL deficiency is correlated with residual enzymatic activity and structural stability of the corresponding mutant ADSL complexes and does not seem to result from genotype-specific disproportional catalytic activities toward one of the enzyme substrates. This suggests that the S-Ado/SAICAr ratio is probably not predictive of phenotype severity; rather, it may be secondary to the degree of the patient's development (i.e., to the age of the patient at the time of sample collection).
References provided by Crossref.org
Expanding clinical spectrum of PAICS deficiency: Comprehensive analysis of two sibling cases
Metabolites of De Novo Purine Synthesis: Metabolic Regulators and Cytotoxic Compounds
Combined Targeted and Untargeted Profiling of HeLa Cells Deficient in Purine De Novo Synthesis
Mass spectrometric analysis of purine de novo biosynthesis intermediates